Pharmaceutical giant  Bristol-Myers Squibb Company (NYSE:BMY) is all set to unveil its fourth quarter and full year 2011 results on January 26, 2012 before the start of trading. The Zacks Consensus Estimate for the fourth quarter is $0.55 (year-over-year increase of 17%) on revenues of $5,472 million (year-over-year increase of 7.1%). For 2011, the Zacks Consensus Estimate is $2.30 (year-over-year increase of 6.5%) on revenues of $21,293 million (year-over-year increase of 9.3%).
Third … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards